Investment in HIV research saves lives and money

Burnet Institute

19 April, 2012

Burnet Institute Director and CEO Professor Brendan Crabb joined Burnet Patron and member of the UNDP Global Commission of HIV and the Law the Hon Michael Kirby AC, CMG, in writing an opinion piece on medical research funding.

Here is how it appeared in The Australian today.

As the federal budget gets nearer, anxious thoughts turn to expenditures. Especially on medical research, always at risk of cuts and short-term perspectives.

The story of AIDS shows why this would be a big mistake.

The 1980s and 90s saw the first AIDS funerals in Australia. It was a desperate and sad time that devastated entire communities.

In those early days doctors were frustrated that they had nothing to offer that could palliate or cure this terrible disease. There was then a brave realisation that social science offered the best immediate course of action.

Importantly, however, this action relied on the knowledge quickly gained by the research community about HIV, especially how the virus could be detected and how it spread. This knowledge quickly rendered our blood supplies safe, unlike much of the rest of the world.

Australia was at the cutting edge of these developments, both at the research and social levels. What ensued was direct outreach to the gay community, injecting drug users, sex workers and others most at risk. Our initiative brought about a rapid plateau in HIV infections in Australia. This was the first of four stages in the fight against the virus.

In the 90s the second stage, medical research, led to the emergence of the triple-combination drug therapies that brought huge relief to those already infected. Many of those living with the disease, including many friends, were able to live a real life again, lives filled with thoughts and pleasures beyond the ravages of this disease.

It brought joy to their souls. To the credit of Australian politicians and medical leaders, again we quickly responded by investing in HIV research and in making these new therapies an essential part of our health system.

By the 2000s there was increasing pressure to provide antiretroviral drugs beyond the world’s wealthy countries to the poor. UNAIDS and the World Health Organization developed strategies that vastly improved the length and quality of life for millions of people living with HIV, including in some of the poorest countries. Australia’s foreign aid has played a significant part in this third stage.

The global financial crisis, however, has proved a setback in the world’s fight against AIDS. Some of the richest countries have wound back funding previously made available for HIV programs in poorer countries.

It is difficult to imagine a more shocking indictment of humanity than if people in less wealthy nations, who have been able to lead full lives with the benefit of antiretroviral therapies, are now to be plunged back into lives of disease and suffering because of the perceived priorities of the people of otherwise wealthy nations.

So here we are at the fourth stage of HIV. A crisis.

It is crucial that this decade sees an increased commitment to research investment. We must move beyond the purely palliative to focus on a cure and a vaccine against this devastating disease.

Australian medical researchers are at the forefront of this fight. The Burnet Institute in Melbourne and the Kirby Institute in Sydney are just two of many medical research institutes where pioneering research into a cure is under way. When the cure and vaccine are found, we will reach the fifth, and hopefully final, phase of AIDS.

The Australian people and their government should remain focused on defeating HIV. There seems to be no end of money available to honour sport in this country and we all expect that. But it would be a tragedy if we don’t similarly honour the work of our medical and social scientists.

The marriage between medical science and social science has delivered excellent outcomes in managing HIV, through scientific breakthroughs, the introduction of needle exchanges, outreach to the gay community and laws that facilitate prevention strategies with sex workers and drug users.

At less than one in 1000 people HIV positive, Australia has a relatively low rate of HIV infection in comparison with other developed nations. If HIV prevalence in Australia reached those levels seen today in the US, about 80,000 people would be infected and require lifelong treatment.

Instead the number sits at 20,000. Our rapid response at home has saved thousands of lives and billions of dollars. This response is a lesson about the value of effective partnerships between affected communities, humanitarian forces, the scientific community and government. We have also helped our neighbours.

While important knowledge of HIV was gained overseas, much was secured in Australia. Our medical research community rapidly translated its knowledge into solutions.

The HIV story affirms that medical research must have a strong local element if the nation is to see maximum benefit from new knowledge. Our ongoing success with HIV demands continued investment.

Investment in medical and social science pays dividends – not only saving money. Saving lives.

Staff Member

Health Issue

Contact Details

For more information in relation to this news article, please contact:

Professor Brendan Crabb AC

Director and CEO; Co-Head Malaria Research Laboratory; Chair, Victorian Chapter of the Association of Australian Medical Research Institutes (AAMRI)




Subscribe to News

Subscribe to receive our latest news: